Gwajin kwayar halitta na iya canza magani don wannan ƙwayar hanji mai saurin ciwo

Share Wannan Wallafa

Appendic cancer is very rare, accounting for less than 1% of gastrointestinal tumors, and there is little scientific data on the disease, which means that the current guidelines for the treatment of colon cancer are recommended for patients with appendic cancer. To understand why some patients with appendix cancer respond to standard treatment for colon cancer, while others do not, the researchers performed a genetic analysis of 703 appendix cancer samples. This is by far the largest study of appendix cancer to compare the mutations present in the two cancer types.

Sakamakon binciken ya tabbatar da cewa maye gurbin kwayoyin halitta a cikin ciwon daji na appendix ya bambanta da na ciwon daji na hanji. Maye gurbi na TP53 da GNAS sune masu hasashen rayuwa a cikin marasa lafiya da ciwon daji na appendix. Ga cututtukan da ba safai ba, samun taswirorin kwayoyin halitta zai taimaka wajen tantance yuwuwar hanyoyin magani saboda ba mu da bayanan gwaji na asibiti don jagorantar daidaitaccen jiyya kamar sauran cututtukan daji. Hakanan mahimmanci, ana iya amfani da bakan maye gurbi a matsayin mai ƙididdigewa don bambance marasa lafiya masu haɗari waɗanda ke buƙatar kulawa mai zurfi don ware su daga marasa lafiya marasa haɗari.

Binciken binciken ya gano cewa abin da ya shafi kansa na daban-daban: Mucinous Adenocarco (kashi 46%), ƙwanƙwarar ƙwayar cuta (30%), kuma Signet). GNAS maye gurbi da ba kasafai ake samu ba a cikin ciwon hanji ya zama ruwan dare a cikin ciwon daji na appendix, musamman adenocarcinoma na mucinous (12%) da peritoneal pseudomyxoma (7.7%). Matsakaicin rayuwa na marasa lafiya tare da ciwace-ciwacen ƙwayoyi tare da maye gurbin GNAS kusan shekaru 5.2, yayin da matsakaicin rayuwa na marasa lafiya tare da ciwace-ciwacen ƙwayoyi tare da maye gurbi na TP52 shine kawai shekaru uku, kuma matsakaicin rayuwa na marasa lafiya ba tare da waɗannan maye gurbi guda biyu ba shine shekaru 72.

This surprising discovery raises the question of whether patients with early-stage GNAS-mutant tumors need to be treated with chemotherapy because it may be cured by surgery alone, so more research is needed to prove it.

Biyan kuɗi zuwa ga Newsletter

Sami sabuntawa kuma kada ku rasa bulogi daga Cancerfax

Toarin Don Bincika

Fahimtar Ciwon Sakin Cytokine: Dalilai, Alamu, da Jiyya
CAR T-Cell far

Fahimtar Ciwon Sakin Cytokine: Dalilai, Alamu, da Jiyya

Gabatarwa Cututtuka, cututtuka na autoimmune, da rigakafi na rigakafi suna daga cikin dalilai masu yawa na cytokine release syndrome (CRS), tsarin tsarin rigakafi mai rikitarwa. Alamun na kullum

Matsayin ma'aikatan lafiya a cikin nasarar CAR T Cell therapy
CAR T-Cell far

Matsayin ma'aikatan lafiya a cikin nasarar CAR T Cell therapy

Ma'aikatan jinya suna taka muhimmiyar rawa a cikin nasarar CAR T-cell far ta hanyar tabbatar da kulawar marasa lafiya a duk lokacin aikin jiyya. Suna ba da tallafi mai mahimmanci yayin sufuri, lura da mahimman alamun marasa lafiya, da gudanar da ayyukan gaggawa na likita idan rikitarwa ta taso. Amsar su da sauri da kulawar ƙwararrun suna ba da gudummawa ga amincin gabaɗaya da ingancin jiyya, sauƙaƙe sauye-sauye masu sauƙi tsakanin saitunan kiwon lafiya da haɓaka sakamakon haƙuri a cikin ƙalubalen shimfidar wurare na ci-gaba na salon salula.

Ana buƙatar taimako? Ourungiyarmu a shirye take don taimaka muku.

Muna fatan samun lafiya cikin sauri na masoyinku da na kusa.

Fara hira
Muna Kan layi! Yi Taɗi da Mu!
Duba lambar
Hello,

Barka da zuwa CancerFax!

CancerFax wani dandali ne na majagaba wanda aka keɓe don haɗa mutane da ke fuskantar ciwon daji na zamani tare da hanyoyin kwantar da hankali kamar CAR T-Cell far, TIL far, da gwaji na asibiti a duk duniya.

Bari mu san abin da za mu iya yi muku.

1) Maganin ciwon daji a kasashen waje?
2) CAR T-Cell far
3) rigakafin cutar daji
4) Shawarar bidiyo ta kan layi
5) Maganin Proton